SENSEX NIFTY
YOU ARE HERE >  Moneycontrol Markets > Announcements Pharmaceuticals
Dr Reddys Laboratories
BSE: 500124|NSE: DRREDDY|ISIN: INE089A01023|SECTOR: Pharmaceuticals
SET ALERT
|
ADD TO PORTFOLIO
|
WATCHLIST
LIVE
BSE
Nov 21, 16:15
3530.05
10.8 (0.31%)
VOLUME 8,580
LIVE
NSE
Nov 21, 16:15
3530.80
2.15 (0.06%)
VOLUME 119,690
Announcements on Dr Reddys Labs

20th-Nov-2014 15:36Source: BSE

Dr Reddys Labs- Dr. Reddy’s announces the Launch of Over-the-Counter Fexofenadine Hydrochloride 60 mg and Pseudoephedrine Hydrochloride 120 mg Extended-Release Tablets

Dr Reddys Laboratories Ltd has informed BSE regarding a Press Release dated November 20, 2014, titled "Dr. Reddy’s announces the Launch of Over-the-Counter Fexofenadine Hydrochloride 60 mg and Pseud...

20th-Nov-2014 15:31Source: NSE

Dr. Reddy's Laboratories Limited

Dr. Reddy''s Laboratories Limited has informed the Exchange regarding a press release dated November 20, 2014 titled "Dr. Reddy''s announces the Launch of Over-the-Counter Fexofenadine Hydrochloride 6...

17th-Nov-2014 12:38Source: BSE

Dr Reddys Labs- Disclosures under Reg.13(4), 13(4A) of SEBI (Prohibition of Insider Trading) Regulations, 1992

G Shankarraragar has submitted the disclosures under Reg.13(4), 13(4A) of SEBI (Prohibition of Insider Trading) Regulations, 1992

14th-Nov-2014 18:09Source: BSE

Dr Reddys Labs- Disclosures under Reg.13(6) of SEBI (Prohibition of Insider Trading) Regulations, 1992

Dr Reddys Laboratories Ltd has submitted the disclosures under Reg.13(6) of SEBI (Prohibition of Insider Trading) Regulations, 1992

29th-Oct-2014 12:39Source: NSE

Dr. Reddy's Laboratories Limited

Dr. Reddy''s Laboratories Limited has submitted to the exchange the standalone financial results along with the Limited Review Report for the period ended 30-Sep-2014.

29th-Oct-2014 12:38Source: NSE

Dr. Reddy's Laboratories Limited

Dr. Reddy''s Laboratories Limited has informed the Exchange regarding a press release dated October 29, 2014 , titled "Dr. Reddy''s Q2 and H1 FY15 Financial Results"

28th-Oct-2014 20:37Source: NSE

Dr. Reddy's Laboratories Limited

Dr. Reddy''s Laboratories Limited has informed the Exchange regarding a press release dated October 28, 2014, titled " Dr. Reddy''s announces the Launch of Sirolimus Tablets, 1 mg and 2 mg".

28th-Oct-2014 18:01Source: BSE

Dr Reddys Labs- Dr. Reddy’s announces the Launch of Sirolimus Tablets, 1 mg and 2 mg

Dr Reddys Laboratories Ltd has informed BSE regarding a Press Release dated October 28, 2014 titled "Dr. Reddy’s announces the Launch of Sirolimus Tablets, 1 mg and 2 mg".

20th-Oct-2014 16:08Source: BSE

Dr Reddys Labs- Disclosures under Reg.13(4), 13(4A) of SEBI (Prohibition of Insider Trading) Regulations, 1992

Subhadra Ummeda has submitted the disclosures under Reg.13(4), 13(4A) of SEBI (Prohibition of Insider Trading) Regulations, 1992

1 2 3 4 5 Next >>
Quick Links for Dr Reddys Laboratories
Explore Moneycontrol
Stocks     A | B | C | D | E | F | G | H | I | J | K | L | M | N | O | P | Q | R | S | T | U | V | W | X | Y | Z | Others
Mutual Funds     A | B | C | D | E | F | G | H | I | J | K | L | M | N | O | P | Q | R | S | T | U | V | W | X | Y | Z
Copyright © e-Eighteen.com Ltd. All rights reserved. Reproduction of news articles, photos, videos or any other content in whole or in part in any form or medium without express written permission of moneycontrol.com is prohibited.